RESET
Digestive function is the foundation of metabolic recovery. What the gut absorbs — and what it doesn't — shapes every outcome in the GLP-1 lifecycle.
The digestive system is the first to change under GLP-1 therapy. Without targeted intervention, it is the last to recover.
What changes
GLP-1 therapy slows gastric motility by design. That slowing — the mechanism responsible for reduced appetite and sustained satiety — simultaneously alters the entire digestive environment. Stomach acid output decreases. Gastric emptying is delayed. The rate at which food is broken down and nutrients are absorbed through the intestinal wall changes materially throughout treatment.
The gut microbiome — the bacterial ecosystem governing digestion, immune function, and metabolic signalling — undergoes documented changes in composition and diversity. The mucosal lining, which acts as the primary barrier between the gut contents and the bloodstream, operates under increased demand throughout this period.
When the medication ends, these adaptations do not immediately reverse. Digestive rhythm, microbial balance, and mucosal integrity all require deliberate support to recalibrate. Without it, the window extends. Symptoms persist. Nutrient absorption remains compromised.
RESET — ZINC L-CARNOSINE
The gut lining is the foundation of everything that follows. If it is compromised, nutrient absorption fails regardless of what is consumed.
Zinc L-Carnosine is a chelated compound with a clinically documented affinity for damaged mucosal tissue — binding preferentially to injured gut lining and releasing zinc locally where repair is needed. Published research in the journal Gut confirmed that Zinc L-Carnosine stabilises small bowel integrity and actively stimulates gut repair processes. A 2022 review in Clinics and Research in Hepatology and Gastroenterology documented its direct cytoprotective and anti-inflammatory action in gastrointestinal mucosal disease — including impaired intestinal permeability.
RESET — L-GLUTAMINE
The intestinal mucosal cells — enterocytes — are among the most rapidly proliferating cells in the body. Their primary fuel is L-Glutamine. Under conditions of caloric restriction and metabolic stress, glutamine availability is reduced precisely when demand is highest.
Depletion of glutamine results in documented deterioration of intestinal barrier function — reduced tight junction protein expression, increased gut permeability, and impaired mucosal repair. A landmark study published in The Lancet (1993) established that glutamine supplementation preserved both gut permeability and villus height in patients under nutritional stress. Subsequent research confirmed its role as a conditionally essential amino acid for intestinal barrier maintenance in adults under catabolic conditions.
RESET — DIGESEB PLUS®
GLP-1 therapy reduces stomach acid output and slows gastric emptying — the two primary mechanisms by which food is broken down before reaching the intestinal wall. When these functions are compromised, food arrives partially undigested. Proteins, fats, and complex carbohydrates that should be absorbed become substrates for fermentation and dysbiosis instead.
DigeSEB Plus® is a patented, clinically validated enzyme complex — Amylases, Proteases, Lipase, Lactase, Cellulase, and supporting enzymes — designed to reactivate the digestive machinery that GLP-1 therapy suppresses. It is not a generic enzyme blend. It is the specific complex used in clinical formulations for compromised digestive function.
RESET — PROBIOTIC COMPLEX + PREBIOTIC FOUNDATION
The bacterial diversity of the gut microbiome decreases meaningfully during periods of significant dietary restriction and gastric motility changes. The three-strain probiotic complex in RESET — Bacillus coagulans, Lactobacillus acidophilus, and Bifidobacterium longum — targets the bacterial populations most directly affected by the GLP-1 lifecycle.
The prebiotic foundation — Inulin from Chicory Root and Partially Hydrolysed Guar Gum — provides the selective fermentation substrate required to sustain and feed those bacterial populations once established. Probiotics without prebiotic support are transit passengers. With it, they have a reason to stay.
RESET — GINGER ROOT EXTRACT (STD. 5% GINGEROLS)
Delayed gastric motility is not only a symptom experienced during GLP-1 therapy — it is a documented physiological consequence that persists after cessation. Ginger Root Extract, standardised to 5% Gingerols — the active compound responsible for its prokinetic effect — supports natural gastric motility without pharmacological intervention.
RESET — OX BILE POWDER (STD. 45% CHOLIC ACID)
Reduced gastric acid output during GLP-1 therapy impairs the bile acid cascade required for fat-soluble nutrient absorption — Vitamins A, D, E, and K among them. Ox Bile Powder, standardised to 45% Cholic Acid, provides exogenous bile salts that support fat emulsification and absorption in a digestive environment where endogenous bile secretion has been disrupted.
The outcome
Digestive integrity is not a secondary concern in the GLP-1 lifecycle. It is the foundation. The gut is the point of entry for every nutrient the body needs to rebuild lean tissue, sustain cognitive function, and recalibrate hormonal balance. If it is not functioning, none of what follows it can work properly.
RESET was built to address that directly — not with general gut health claims, but with ingredients that target the specific, documented consequences of what GLP-1 therapy does to the digestive system.